Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 6 de 6
Filter
Add more filters










Language
Publication year range
1.
J Diet Suppl ; 16(5): 602-610, 2019.
Article in English | MEDLINE | ID: mdl-29958051

ABSTRACT

Tuberculosis (TB) has become the most important infectious disease to see resurgence worldwide. In 2014, there were 9.6 million documented cases worldwide with a mortality of almost 1.5 million (Global Tuberculosis Report 2014). One of the Millennium Development Goals set by the United Nations was the reversal of the TB epidemic, which has been achieved worldwide with an 18% lower incidence of TB globally compared to the incidence in the year 2000. Though efficient intervention has brought down the relative incidence and mortality of TB globally, the fact remains that one third of the world population has latent TB infection, and 10% of people with latent TB infection develop active TB at some point in their life (The Facts about Tuberculosis 1995). Risk factors that prompt the reactivation of latent TB into active TB are a compromised immune system, HIV, malnutrition, and use of tobacco. In developing and underdeveloped economies, malnutrition and undernutrition play a major role in subverting the immune system and reactivating the latent TB infection. Undernutrition is one of the major factors in India and Southeast Asia leading to an increase in TB infections. Once tuberculosis sets in, it leads to an increase in metabolism and a decrease in appetite that compounds the already present malnutrition. Drawing on previous studies, we have aimed at understanding the relationship between malnutrition and TB infection and making minimal recommendations for corrective action.


Subject(s)
Malnutrition/complications , Tuberculosis/complications , Antitubercular Agents/adverse effects , Antitubercular Agents/pharmacokinetics , Chemical and Drug Induced Liver Injury/etiology , HIV Infections/complications , Humans , Latent Tuberculosis/complications , Latent Tuberculosis/epidemiology , Latent Tuberculosis/immunology , Malnutrition/immunology , Micronutrients/deficiency , Nutrition Therapy , Nutritional Status , Prognosis , Risk Factors , Tuberculosis/epidemiology , Tuberculosis/immunology
2.
Int J Infect Dis ; 71: 53-55, 2018 Jun.
Article in English | MEDLINE | ID: mdl-29653201

ABSTRACT

OBJECTIVES: The serological detection of IgM antibodies is the most widely used test to diagnose scrub typhus infection. However, the kinetics of IgM and IgG antibodies post-infection remain elusive, which could contribute to false positivity. The objective of this study was to document the nature of the evolution of these antibody titres after infection. METHODS: Adult patients previously confirmed to have scrub typhus by IgM ELISA, positive PCR, or both, were included in this cross-sectional study. The levels of IgM and IgG antibodies in serum samples were tested using an ELISA and the distribution curve was plotted. RESULTS: Two hundred and three patients were included in this study. Post-infection serum sampling was done between 1 month and 46 months after documented infection. IgM levels declined gradually but remained elevated above the diagnostic cut-off for up to 12 months post-infection. However, IgG levels continued to rise reaching a peak at 10 months, followed by a gradual decline over several months. In the majority of cases, the IgG levels remained above the cut-off threshold for more than 36 months. CONCLUSIONS: Clinicians need to be cautious in using a single serum sample for the detection of IgM to diagnose scrub typhus, as it remains elevated for up to 12 months after the infection, whereas the serum IgG level could be used as an indicator of past infection.


Subject(s)
Antibodies, Bacterial/blood , Immunoglobulin G/blood , Immunoglobulin M/blood , Scrub Typhus/diagnosis , Adult , Cross-Sectional Studies , Female , Humans , Kinetics , Male , Middle Aged , Scrub Typhus/immunology
3.
Ren Fail ; 38(7): 1115-21, 2016 Aug.
Article in English | MEDLINE | ID: mdl-27183989

ABSTRACT

Nephrotoxicity is a rare complication caused by anti-tuberculosis therapy-induced oxidative stress. The Cyanobacterium Spirulina fusiformis Voronikhin belonging to Oscillatoriaceae family is used traditionally as a source of antioxidants against oxidative stress. We aimed to investigate the efficacy of S. fusiformis in modifying isoniazid (INH) and rifampicin (RIF)-induced changes in Wistar rat kidneys. Animals were divided into six groups: normal control rats; toxic control (INH & RIF-50 mg/kg b.w./d each; p.o.); INH & RIF + S. fusiformis (400 mg/kg b.w./d); INH & RIF + S. fusiformis (800 mg/kg b.w./d); S. fusiformis (800 mg/kg b.w./d) alone-treated rats; INH & RIF + silymarin (25 mg/kg b.w./d). Study duration was 28 d after which blood and kidneys were analyzed. We also studied the binding and interactions of the transcription factors Liver X Receptor (LXR) and Farnesoid X Receptor (FXR) with INH, RIF, and representative active compounds of S. fusiformis by in silico methods. INH & RIF treatment caused significant (p< 0.05) decrease in antioxidant levels and significant (p< 0.05) increase in the levels of creatinine, urea, and uric acid showing impaired kidney function. Spirulina fusiformis ameliorated these effects in a dose dependent manner. Histological examination of kidneys supported these findings. Results of the in silico analyses showed that selected active components of S. fusiformis interact with LXR and FXR and could be a possible mechanism of action. S. fusiformis rendered protection against anti-tuberculosis drugs-induced oxidative stress in kidney tissues of rats.


Subject(s)
Acute Kidney Injury/drug therapy , Antioxidants/metabolism , Antitubercular Agents/adverse effects , Kidney/metabolism , Oxidative Stress/drug effects , Spirulina/chemistry , Acute Kidney Injury/chemically induced , Animals , Antioxidants/analysis , Creatinine/blood , Disease Models, Animal , Female , Humans , Isoniazid/adverse effects , Kidney/pathology , Lipid Peroxidation , Liver/drug effects , Protective Agents/administration & dosage , Rats , Rats, Wistar , Receptors, Cytoplasmic and Nuclear/metabolism , Rifampin/adverse effects , Silymarin/administration & dosage , Urea/blood , Uric Acid/blood
4.
J Integr Med ; 13(2): 115-21, 2015 Mar.
Article in English | MEDLINE | ID: mdl-25797642

ABSTRACT

OBJECTIVE: The purpose of the present study was to evaluate the nephroprotective and antioxidant properties of Triphala against bromobenzene-induced nephrotoxicity in female Wistar albino rats. METHODS: Animals were divided into five groups of six rats and treated as follows: Group I was a normal control and received no treatment, Group II received only bromobenzene (10 mmol/kg), Groups III and IV received bromobenzene and Triphala (250 and 500 mg/kg, respectively), Group V received Triphala alone (500 mg/kg), and Group VI received bromobenzene and silymarin (100 mg/kg). Antioxidant status and serum kidney functional markers were analyzed. RESULTS: Bromobenzene treatment resulted in significant (P< 0.05) decreases in the activities of antioxidant enzymes such as catalase, superoxide dismutase, glutathione-S-transferase and glutathione peroxidase as well as total reduced glutathione. There was a significant (P< 0.05) increase in lipid peroxidation in kidney tissue homogenates. There were significant (P< 0.05) reductions in the levels of serum total protein and albumin as well as significant (P< 0.05) increases in serum creatinine, urea and uric acid. The oral administration of two different doses (250 and 500 mg/kg) of Triphala in bromobenzene-treated rats normalized the tested parameters. The histopathological examinations of kidney sections of the experimental rats support the biochemical observations. CONCLUSION: Triphala treatment alleviated the nephrotoxic effects of bromobenzene by increasing the activities of antioxidant enzymes and reducing the levels of lipid peroxidation and kidney functional markers.


Subject(s)
Acute Kidney Injury/prevention & control , Kidney , Phyllanthus emblica , Plant Preparations , Terminalia , Acute Kidney Injury/chemically induced , Acute Kidney Injury/diagnosis , Acute Kidney Injury/metabolism , Animals , Antioxidants/pharmacology , Bromobenzenes/pharmacology , Disease Models, Animal , Female , Kidney/metabolism , Kidney/pathology , Kidney Function Tests , Medicine, Ayurvedic , Plant Preparations/chemistry , Plant Preparations/pharmacology , Plant Structures , Protective Agents/pharmacology , Rats , Rats, Wistar , Silymarin/pharmacology , Treatment Outcome
5.
Journal of Integrative Medicine ; (12): 115-21, 2015.
Article in English | WPRIM (Western Pacific) | ID: wpr-671900

ABSTRACT

The purpose of the present study was to evaluate the nephroprotective and antioxidant properties of Triphala against bromobenzene-induced nephrotoxicity in female Wistar albino rats.

6.
Toxicol Mech Methods ; 24(8): 584-92, 2014 Dec.
Article in English | MEDLINE | ID: mdl-25137345

ABSTRACT

Therapy using Isoniazid (INH) and Rifampicin (RIF) leads to induction of hepatotoxicity in some individuals undergoing anti-tuberculosis treatment. In this study, we assessed the effect of Spirulina fusiformis on INH and RIF induced hepatotoxicity in rats compared with hepatoprotective drug Silymarin. Induction of hepatotoxicity was measured by changes in the liver marker enzymes (aspartate transaminase, alanine transaminase, and alkaline phosphatase). The antioxidant status was also analyzed in liver tissue homogenate and plasma by measurement of superoxide dismutase, catalase, glutathione-S-transferase, glutathione reductase, and lipid peroxidation levels. We also aimed to study the binding and interactions of the transcription factors Pregnane X Receptor (PXR) and Farnesoid X Receptor (FXR) with INH, RIF, and representative active compounds of Spirulina fusiformis by in silico methods. The administration of INH and RIF resulted in significant (p < 0.05) decrease in the antioxidant levels and total protein levels. There was also a significant (p < 0.05) increase in the levels of liver marker enzymes. Spirulina fusiformis was seen to protect the parameters from significant changes upon challenge with INH and RIF in a dose-dependent manner. This was corroborated by histological examination of the liver. The results of the in silico analyses further support the wet lab results.


Subject(s)
Antibiotics, Antitubercular/adverse effects , Chemical and Drug Induced Liver Injury/prevention & control , Liver/drug effects , Models, Molecular , Probiotics/therapeutic use , Protective Agents/therapeutic use , Spirulina , Animals , Antibiotics, Antitubercular/chemistry , Antibiotics, Antitubercular/metabolism , Chemical and Drug Induced Liver Injury/blood , Chemical and Drug Induced Liver Injury/metabolism , Chemical and Drug Induced Liver Injury/pathology , Drug Therapy, Combination/adverse effects , Female , Isoniazid/adverse effects , Isoniazid/antagonists & inhibitors , Isoniazid/chemistry , Isoniazid/metabolism , Ligands , Lipid Peroxidation , Liver/metabolism , Liver/pathology , Molecular Conformation , Molecular Docking Simulation , Organ Size/drug effects , Oxidoreductases/blood , Oxidoreductases/metabolism , Pregnane X Receptor , Probiotics/administration & dosage , Probiotics/chemistry , Protective Agents/administration & dosage , Protective Agents/chemistry , Rats, Wistar , Receptors, Cytoplasmic and Nuclear/chemistry , Receptors, Cytoplasmic and Nuclear/metabolism , Receptors, Steroid/chemistry , Receptors, Steroid/metabolism , Rifampin/adverse effects , Rifampin/antagonists & inhibitors , Rifampin/chemistry , Rifampin/metabolism , Silymarin/therapeutic use
SELECTION OF CITATIONS
SEARCH DETAIL
...